421 related articles for article (PubMed ID: 29968906)
1. Epithelial-to-mesenchymal transition and cancer stem cells contribute to breast cancer heterogeneity.
Hong D; Fritz AJ; Zaidi SK; van Wijnen AJ; Nickerson JA; Imbalzano AN; Lian JB; Stein JL; Stein GS
J Cell Physiol; 2018 Dec; 233(12):9136-9144. PubMed ID: 29968906
[TBL] [Abstract][Full Text] [Related]
2. Role of microRNAs in the regulation of breast cancer stem cells.
Liu S; Clouthier SG; Wicha MS
J Mammary Gland Biol Neoplasia; 2012 Mar; 17(1):15-21. PubMed ID: 22331423
[TBL] [Abstract][Full Text] [Related]
3. The epithelial-mesenchymal transition and cancer stem cells: functional and mechanistic links.
Liu X; Fan D
Curr Pharm Des; 2015; 21(10):1279-91. PubMed ID: 25506898
[TBL] [Abstract][Full Text] [Related]
4. VEGF-mediated angiogenesis links EMT-induced cancer stemness to tumor initiation.
Fantozzi A; Gruber DC; Pisarsky L; Heck C; Kunita A; Yilmaz M; Meyer-Schaller N; Cornille K; Hopfer U; Bentires-Alj M; Christofori G
Cancer Res; 2014 Mar; 74(5):1566-75. PubMed ID: 24413534
[TBL] [Abstract][Full Text] [Related]
5. EMT in breast cancer stem cell generation.
Ansieau S
Cancer Lett; 2013 Sep; 338(1):63-8. PubMed ID: 22634497
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.
Glackin CA
Enzymes; 2018; 44():83-101. PubMed ID: 30360816
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA control of epithelial-mesenchymal transition in cancer stem cells.
Hao J; Zhang Y; Deng M; Ye R; Zhao S; Wang Y; Li J; Zhao Z
Int J Cancer; 2014 Sep; 135(5):1019-27. PubMed ID: 24500893
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasis.
Neelakantan D; Drasin DJ; Ford HL
Cell Adh Migr; 2015; 9(4):265-76. PubMed ID: 25482627
[TBL] [Abstract][Full Text] [Related]
9. Cancer Stem Cells and Epithelial-to-Mesenchymal Transition in Cancer Metastasis.
Celià-Terrassa T; Jolly MK
Cold Spring Harb Perspect Med; 2020 Jul; 10(7):. PubMed ID: 31570380
[TBL] [Abstract][Full Text] [Related]
10. Concise Review: Stem Cells and Epithelial-Mesenchymal Transition in Cancer: Biological Implications and Therapeutic Targets.
Sato R; Semba T; Saya H; Arima Y
Stem Cells; 2016 Aug; 34(8):1997-2007. PubMed ID: 27251010
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance.
Mallini P; Lennard T; Kirby J; Meeson A
Cancer Treat Rev; 2014 Apr; 40(3):341-8. PubMed ID: 24090504
[TBL] [Abstract][Full Text] [Related]
12. Pomegranate Extract Alters Breast Cancer Stem Cell Properties in Association with Inhibition of Epithelial-to-Mesenchymal Transition.
Nallanthighal S; Elmaliki KM; Reliene R
Nutr Cancer; 2017 Oct; 69(7):1088-1098. PubMed ID: 28976208
[TBL] [Abstract][Full Text] [Related]
13. Harnessing the BMP signaling pathway to control the formation of cancer stem cells by effects on epithelial-to-mesenchymal transition.
Bosukonda A; Carlson WD
Biochem Soc Trans; 2017 Feb; 45(1):223-228. PubMed ID: 28202676
[TBL] [Abstract][Full Text] [Related]
14. Role of p38γ MAPK in regulation of EMT and cancer stem cells.
Xu M; Wang S; Wang Y; Wu H; Frank JA; Zhang Z; Luo J
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3605-3617. PubMed ID: 30251680
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer stem cells and epithelial mesenchymal plasticity - Implications for chemoresistance.
Pinto CA; Widodo E; Waltham M; Thompson EW
Cancer Lett; 2013 Nov; 341(1):56-62. PubMed ID: 23830804
[TBL] [Abstract][Full Text] [Related]
16. miR-375 inhibits cancer stem cell phenotype and tamoxifen resistance by degrading HOXB3 in human ER-positive breast cancer.
Fu H; Fu L; Xie C; Zuo WS; Liu YS; Zheng MZ; Yu JM
Oncol Rep; 2017 Feb; 37(2):1093-1099. PubMed ID: 28075453
[TBL] [Abstract][Full Text] [Related]
17. Landscape perspectives of tumor, EMT, and development.
Yu C; Liu Q; Chen C; Yu J; Wang J
Phys Biol; 2019 Jul; 16(5):051003. PubMed ID: 31067516
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of 26S proteasome catalytic activity promotes epithelial-mesenchymal transition.
Banno A; Garcia DA; van Baarsel ED; Metz PJ; Fisch K; Widjaja CE; Kim SH; Lopez J; Chang AN; Geurink PP; Florea BI; Overkleeft HS; Ovaa H; Bui JD; Yang J; Chang JT
Oncotarget; 2016 Apr; 7(16):21527-41. PubMed ID: 26930717
[TBL] [Abstract][Full Text] [Related]
19. Novel cancer stem cell targets during epithelial to mesenchymal transition in PTEN-deficient trastuzumab-resistant breast cancer.
Sun L; Burnett J; Gasparyan M; Xu F; Jiang H; Lin CC; Myers I; Korkaya H; Liu Y; Connarn J; He H; Zhang N; Wicha MS; Sun D
Oncotarget; 2016 Aug; 7(32):51408-51422. PubMed ID: 27285982
[TBL] [Abstract][Full Text] [Related]
20. Concise review: breast cancer stem cells: regulatory networks, stem cell niches, and disease relevance.
Guo W
Stem Cells Transl Med; 2014 Aug; 3(8):942-8. PubMed ID: 24904174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
